RecruitingNCT06236880

A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD

This recruiting study focuses on depression and currently lists sites or participation links in United Kingdom.

DepressionOtherFrom 18 Years to 65 Years

In plain English

Key information made simple

This study exists to see whether the medication GM-2505 is workable and worth testing more broadly. Researchers are trying to understand how people respond to the medication GM-2505 in practice and what may need to be adjusted. For people living with Depression, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could help shape larger studies and better designed support in the future. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a clinic, with sites including MAC Clinical Research in Manchester. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually matching the main diagnosis, while common reasons not to take part include other factors that could make participation unsuitable and other clinical factors that could make participation unreliable or unsafe. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT06236880. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular follow-up, often through questionnaires or interviews.

Requires travel, with in-person participation in United Kingdom.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com